Doctor Care Anywhere Group PLC · ASX:DOC

Doctor Care Anywhere — H1 2026 Earnings Presentation

14 slides from Doctor Care Anywhere's earnings presentation, Sep 3, 2026

  1. Slide 1: 1H26 Results Presentation

    For personal use only Doctor Care Anywhere Group plc 1H26 Results Presentation Six months ended 30 June 2026 “Funding our own growth from operating cash” ASX: DOC 03 September 2026 This presentation has been approved by the Board of Directors of Doctor Care Anywhere Group plc for release to the Aust

  2. Slide 2: Important Notice and Disclaimer

    Important Notice and Disclaimer​ For personal use only This presentation is for information purposes only and it is not Neither the Company nor any of its directors, officers, This presentation may contain forward-looking statements financial product or investment advice. The presentation is not emp

  3. Slide 3: Who we are: One of the UK's largest private providers of telehealth services

    Who we are: One of the UK's largest private providers of telehealth services For personal use only The Company works with insurers, healthcare providers and corporate customers to connect patients to a range of digitally enabled telehealth services on its proprietary platform. WHO WE SERVE WHAT WE D

  4. Slide 4: FY25 was consolidation… FY26 is focus and diversification

    FY25 was consolidation… FY26 is focus and diversification. For personal use only DCA has a proven platform, clinical credibility, and the strategic building blocks in place to lead the digital workforce health market. • The cost base was reset and the saving has maintained THE TURNAROUND 1. FY25 del

  5. Slide 5: Revenue grew, labour costs fell, and free cash flow more than doubled

    Revenue grew, labour costs fell, and free cash flow more than doubled For personal use only Six months to 30 June 2026 against the restated prior comparative period 1H26 AT A GLANCE Revenue EBITDA FREE CASH FLOW £20.4m £2.6m £1.5m up 6.3% up 27.1% up 111% vs £19.2m vs £2.1m restated vs £0.7m CONSULT

  6. Slide 6: A 6.3% revenue increase converted into a 111% increase in free cash flow

    A 6.3% revenue increase converted into a 111% increase in free cash flow For personal use only Statutory, six months to 30 June 2026 against restated H1 25. +111% +27.1% +8.8% +6.3% -4.9% Revenue Total labour cost Contribution EBITDA Free cash flow £20.4m £14.4m £8.6m £2.6m £1.5m £0.9m from DCA Medi

  7. Slide 7: Three quarters of the revenue increase came through acquisition

    Three quarters of the revenue increase came through acquisition For personal use only Statutory revenue by stream, note 3. Medicspot revenue is reported within subscription Where the £1.2m increase came from And what the streams are H1 25 H1 26 Utilisation revenue grew 2.0% to £18.2m • The existing

  8. Slide 8: Margin expanded at both the contribution and the EBITDA line

    Margin expanded at both the contribution and the EBITDA line For personal use only H1 25 restated to H1 26. Contribution and gross profit are the same measure following the FY25 reclassification CONTRIBUTION EBITDA CONTRIBUTION MARGIN £7.9m £8.6m £2.1m £2.6m 42.0% up 0.9 points on revenue growth of

  9. Slide 9: Operating cash flow almost doubled and free cash flow more than doubled

    Operating cash flow almost doubled and free cash flow more than doubled For personal use only Six months to 30 June 2026. Free cash flow is a non-IFRS measure, defined on this slide FREE CASH FLOW (excl. Financing) CASH WALK, SIX MONTHS TO 30 JUNE 2026 £1.5m up 111%, from £0.7m +£3.8m £2.3m £0.4m CA

  10. Slide 10: How we thrive

    How we thrive For personal use only A clinically governed operating model that scales where others break Enterprise and NHS-grade Clinical systems, Digitally-trained clinical Operations-embedded governance not individuals workforce technology CQC-regulated, audit-ready Standardised pathways Recruitm

  11. Slide 11: The Market Opportunity

    The Market Opportunity For personal use only DCA operates in the largest, fastest-monetising segment of UK digital health UK Telehealth Access to care Self-pay Consumers Virtual GP Services £6.3bn 7.3m 50m Most Used Opportunity to On NHS waiting 70% willing to pay Employer provided seize - growing l

  12. Slide 12: GLP-1 is already a mainstream treatment, and the NHS can reach only a fraction of the demand

    GLP-1 is already a mainstream treatment, and the NHS can reach only a fraction of the demand For personal use only Medicspot was acquired on 8 May 2026. The market it operates in, and the two channels that reach it. MEDICSPOT | THE MARKET IT OPENS GLP-1 USERS, UK CONSIDERING STARTING NHS ROLLOUT 2.4

  13. Slide 13: Contact details

    For personal use only Contact details Matthew Pearson Investor Relations [email protected] Doctor Care Anywhere Group plc 19-21 Great Portland Street London W1W 8QB United Kingdom Company number 08915336 ARBN 645 163 873 ASX: DOC 13 © 2026 Doctor Care Anywhere

  14. Slide 14: How the H1 comparatives differ from what was reported in August 2025

    APPENDIX: How the H1 25 comparatives differ from what was For personal use only reported in August 2025 All changes are presentational. None affects cash, profit or net assets in either period H1 25 MEASURE ANNOUNCED AUG 2025 RESTATED REASON Gross profit margin 63.3% 41.0% £4.3m reclassified from ad

Doctor Care Anywhere Group — H1 2026 Earnings Presentation on 6ix